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INTRODUCTION 
 “What is most difficult of all? It is what appears most simple. To see with 
yours eyes what lies in front of your eyes” Goths. 
 Skin, though ubiquitous, is remarkably heterogeneous organ. Because of 
its complexity, wide varieties of tumours arise from it. Thus there may be 
tumours from cetodermal origin and mesodermal origin, such as tumours of skin 
appendages, pigment cells, vessels, muscles and lymphoid tissue. Their diversity 
combined with body of descriptive data (clinical, histological, and therapeutic) 
amassed over the past century and deepened in various literature produces 
confusion. 
 Interpretation of clinical picture is difficult, for identical manifestations 
may result from widely difficult causes. However, the great advantage of dealing 
with cutaneous surgery is that of dealing with an organ that can be seen and felt. 
 The distinction between normal and pathological structures, benign & 
malignant neoplasm are more difficult to define when they  appear in skin than 
when found elsewhere. They may also be harbinger of metabolic & visual 
disturbance. 
 Malignant skin tumour usually show a disorganized structural pattern of 
individual cells frequently exhibit structured abnormality such as abnormal size, 
shape, chromatin pattern and nucleus to cytoplasm ratio. These lesions show 
infiltrative growth usually rapidly and mitotic figures are not uncommon. 
Malignant tumours show infiltrative growth with inversion and destruction of 
tissue. Metastases are characteristic of malignant tumour. 
 The potentiality to give rise to metastases is decisive evidence for the 
malignancy of tumors. For metastases to form, tumour cells must possess a 
degree of autonomy. This autonomy enables malignant cells to induce foreign 
tissue to furnish the necessary stroma in which they can multiply. In addition to 
malignant tumours located largely in situ. Although cytologically malignant, they 
are biologically still benign. 
 The criteria for benign and malignancy must be altered somewhat in 
dealing with skin tumours. For example, one of the rapidly growing tumours of 
skin, keretoacanthoma, is benign and the most common skin tumour, basal cell 
carcinoma is slow growing and usually does not metastasize. 
 While cancers of the skin are more amenable to therapeutic measures than 
are cancers of other sites, accurate diagnosis presents many problems because of 
the variations in histological types, of metastasis and different responses to the 
therapy. 
 Essentially the principle involved is treatment of skin cancers is early 
diagnosis, adequate treatment & careful follow up. 
 Thus, the stud of primary malignant sign tumours is perhaps more 
intriguing, fascinating & challenging. 
AIMS OF THE STUDY 
 As primary malignant skin tumors comprise of wide variety, it is 
considered worthwhile to study the following. 
1. Common & unusual manifestations of skin tunors seen at GRH, 
Madurai. 
2. Validity of clinical & histopathological diagnosis 
3. Management of skin malignancies either palliatively or curatively 
by following standard procedures in the literature. 
4. Education of the patients about harmful effects of etiological 
factors and early detection of precursor lesion in prevention of skin 
cancer, so that debilitating surgeries can be avoided later on. 
 
 
 
 
 
 
  
 
 
 
REVIEW OF LITERATURE 
Embryology and histology of the skin 
 The skin has two fold origin; (a) a superficial layer, epidermis which 
develop from the surface ectoderm,  and (b) a deep layer, the dermis, which 
develops from the underlying mesenchyme. 
MORPHOLOGY: Skin is the major organ of the body, forming about 8% of 
its total mass and having an area of berween 1.2 to 2.2 sq meters. The thickness 
of skin varies from 1.5mm on the eyelid to up to 4mm on the back. Skin covers 
the entire surface of the body. 
Anatomy of Skin 
Skin is the largest organ in the body. 
 An outer keratinizing stratified squamous epithelium, which is self 
regenerating – the epidermis. 
 An underlying tough supporting and nourishing layer of 
fibroblastic tissue – the dermis. 
 A variable deep layer, mainly adipose tissue – the hypodermis or 
sub cutis.  
Epidermis: Cells produced by mitosis in the germinal basal layer adjacent to the 
dermis undergo maturational changes concerned with the production of keratin. 
The outer keratinized layer is shed continuously and is replaced by the 
progressive movement and maturation of cells from the germinal layer; thus all 
of the cells of this lineage are described as keratinocytes. The rate of mitosis in 
the germinal layer is generally equal to the rate of desquamation of keratin from 
the outer surface, in humans, the process of  maturation of a cell through to 
desquamation takes from 25 to 50 days, being rapid in areas exposed to heavy 
frictional forces. 
 Stratum basale 
 Stratum spinosum 
 Stratum granulosum 
 Stratum corneum 
Melanocytes: M as seen in micrograph (a) are responsible for the synthesis and 
release of the brown pigment melanin, which is largely responsible for skin 
coloration. They are located in the basal layer of the epidermis and appear as 
round cells with pale – staining cytoplasm scattered infrequently between the low 
columnar basal cells. From this cell body there are numerous long cytoplasmic 
processes, which run in the spaces between the keratinocytes of the stratum 
granulosum. Melanocyte cytoplasm contains secialized membrane- bound oval 
granules called premelanosomes and melanosomes, which synthesize the 
pigment melanin. 
Skin appendages: Skin has a variety of appendages, principally hairs, sebaceous 
glands and sweat glands, which are derived embryologically from the surface 
epithelium (epidermis). 
Hairs: Hairs are highly modified keratinized structures produced by hair follicles, 
which are essentially cylindrical down growths of the surface epithelium, 
unsheathed by collagenous  tissue. 
Sebaceous glands: One or more sebaceous glands are associated with each hair 
follicle; these glands secrete an oily substance called sebum onto the hair surface 
in the upper part of the follicle. Sebum acts as a waterproofing and moisturizing 
agent for the hair and skin surface. 
Sweat glands: In most areas of the skin, sweat glands are simple, coiled tubular 
glands, which secrete a watery fluid onto the skin surface by the process of 
merocrine secretion. 
FUNCTION: 
Protection: Provides protection against ultraviolet rays, mechanical, chemicals, 
and thermal insult. Its relatively impermeable surface prevents dehydration; act a 
s physical barrier to invasion by microorganism. 
Sensation: Skin is the largest sensory organ in the body. Contains variety of 
receptor for touch, pressure, pain and temperature. 
Thermo regulation: body is insulated against heat loss by the presence of hair and 
subcutaneous, adipose tissue. Heat loss is facilitated evaporation of sweat from 
the skin surface and increased blood flow through the rich vascular network or 
the dermis. 
Metabolic function: Subcutaneous adipose tissues constitute a major store in 
energy mainly in the form of triglycerides. Vitamin D is synthesized  in the 
epidermis and supplement that derived from dietary source. 
Synthesis of melanin: Melanin pigment gives black colour to the skin and hair 
(Greek word Melanin means black). 
1 st step 
By Hydroxylation. Tyrosinase (mono oxygenase contains copper) 
Tyrosine                                                                                                              
DOPA 
2nd step  converted to 
(dihydroxy Pheny1 alanine)                   Dopaquine                 Indoliquine 
         through a series of  
         reaction involving 
         decorboxylation 
and  
         oxidation of side 
chain 
Indoliquine is finally polymerized to form melanin. 
Step 1 and 2 are enzyme- based reaction 
Melanin synthesis is controlled by – 
1. MSH 
2. ACTH 
3. Sex hormone both estrogen and androgen 
CLASSIFICATION OF MALIGNANT SURFACE EPIDERMAL TUMOURS. 
BY WORLD HEALTH ORGANIZATION.3 
1. Squamous cell carcinoma 
• Spindle cell 
• Acantholytic 
• Verrucous 
• Horn forming 
• Lymphoepithelial 
 
2. Basal cell carcinoma 
• Multifocal superficial (Superficial multicentric) 
• Nodular (Solid, adenoid cystic) 
• Infiltrating 
• Non-Sclerosing 
• Sclerosing (desmoplastic morphemic) 
3. Fibroepithelial 
4. Basal cell carcinoma with adnexal differentiation 
• Follicular 
• Eccrine 
5. Basosquamous carcinoma. 
6. Keratotic basal cell carcinoma 
7. Pigmented basal cell carcinoma 
8. Basal cell carcinoma in basal cell nevus syndrome 
9. Micronodular basal cell carcinoma 
10. Uncommon cutaneous malignaney. 
Uncommon cutaneous malignancies 
 1. Cutaneous angiosarcoma  
- Rare, aggressive soft tissue sarcoma derived from blood or lymphatic 
endothelium.  
Presents as flat, painless often pruritic macule or plague with a red, blue or 
purple color that develops into a mass and ulcerates if left in place.  
High incidence of lympha node metastasis (15%).  
2. Dermatofibrosarcoma protuberans  
* Low grade sarcoma arising from dermal fibroblasts.  
Appears as smooth nodule in or immediately beneath the skin.  
3. Kaposis sarcoma  
 Low grade soft tissue malignancy arises from lymphatic or vascular 
endothelial cells in the skin.  
 Common in AIDS and other immunosuppressed states.  
4. Merkel cell carcinoma  
 Derived from neuroendocrine cells.  
 Rapidly growing red-blue nodule most frequently in Head and neck area 
in older individuals.  
11. Adnexal Tumors  
 Hair follicle  
1. Trichoepithelioma  
2. Trichofolliculoma  
Sebaceous Gland  
1. Sabaceous adenoma  
2. Sebaceous epithelioma  
Apocrine Gland  
1. Syringocystadenoma  
2. Papilliferous  
 Ecrine gland  
  Syringoma  
 
DESCRIPTIVE EPIDEMIOLOGY 
Cutaneous malignancies are the malignancies whose incidence is rising 
faster than any other malignancies. Hence it is aptly called ‘an epidemic of 
cutaneous malignancies. 
The cutaneous malignancies accounts for about 1% of the total 
malignancy incidence. 
All cutaneous malignancies are more common in whites than blacks and 
occurs less commonly in Asian and black population. 
The incidence of Non melanoma cancer ranges from 1,00,000 in Japan to 
1000 per 1,00,000 population in Australia.  The basal cell carcinoma & squamous 
cell carcinoma occurs in a ratio of 4:1. Both are more common in males with 
male to female ratio of 3:1. The incidence of squamous cell carcinoma is 38 per 
1,00,000 population per annum. Basal cell carcinoma accounts for 70% of the 
NMSC. 
The incidence of malignant melanoma varies from 30-50 cases per 
1,00,000 population per annum with preponderance in males. 
Geographical Variations 
 All cutaneous malignancies are more common in countries in which sun 
exposure is more, like Australia. The cutaneous malignancies are more common 
in population of Celtic ancestry. 
 
OCCUPATIONAL SKIN CANCER 
Definition: Occupational cancer is a malignancy that results from 
exposure to carcinogenic forces in an occupational environment. 
GENERAL CONSIDERATION ABOUT OCCUPATIONAL CANCER 
Predisposing factors 
a) Extrinsic factors 
1. Nature of carcinogen: There are about 200 polycyclic 
hydrocarbons, which are carcinogenic apart from arsenic & 
ionizing radiation. The activity of these carcinogens is affected by 
presence of Co – carcinogens or anticarcinogens. 
2. Physical states of the carcinogens. The effect of carcinogens in the 
form of dust, aerosol liquid, solid or radiation will vary according 
to physical state and its capacity to adhere to the skin or penetrate 
the clothing. 
3.  Nature of the occupation. The  site of lesion is determined by 
working position, technical demand of job, land environment 
condition. 
4.  Intensity of exposure. The effect is directly proportional to it. 
5. Duration of exposure. The longer the period of exposure, the more 
inevitable the out come. This may vary with the individual and 
carcinogens. 
b) Intrinsic factors: 
1) Age: The duration of exposure, to carcinogens may amount to 
many years. Senile atrophic and hypertrophy changes may play a 
part, but intensity and duration of exposure are of Greater 
importance than the carcinogens. 
2) Sex: Males are more affected than females. 
3) Race: Epithelioma is less common in black people because of their 
more efficient protection against UV rays. 
4) Heredity: The influence of heredity is doubtful in occupational 
cancer though it may play part in personal idiosyncrasy. 
5) Nature of the skin: Sebaceous nature of the skin like scrotum, may 
take up the fat soluble carcinogens. 
6) Personal habits: The tendency to reach the nose or ear with oily or 
tarry hands, general lack of personal cleanliness may determine the 
site of cancer. 
7) Special idiosyncrasy: Many people exposed to carcinogenic 
material never show any sign of cancer. There may be in certain 
individuals a metabolic or heredity influence, which operates in 
direction or the other. 
 
 
AGENTS PRODUCING SKIN CANCER 
A. CHEMICAL AGENTS 
1. Arsenic (inorganic or organic). 
2. Combustion & distillation products of coal, soot, coal tar, 
anthralenes. 
3. Distillation products of  oils, lubrication oil, crude paraffin 
oils. 
4. Processed petroleum products, fuel oil, lubrication oil, crude 
paraffin oil, and petroleum tars, asphalt carbon black. 
5. Combustion of natural gas, types of carbon black. 
B. PHYSICAL AGENTS 
1. Non ionizing radiations, ultraviolet light. 
2. Ionizing radiations; X-rays. 
 
 
 
 
 
 
 
NON-MELANOMA SKIN CANCER 
GENO DERMATOSES 
 Hereditary syndromes enlisted with skin cancers are part of a group of 
rare disorder characterized by one or more of a large number of abnormities. 
Their syndromes are known as geno dermatoses. 
(i) Nevoid basal cell carcinoma syndrome.(GORLIN 
SYNDROME) 
(ii) Xeroderma pigmentosum 
(iii) Epidermodysplasia verruciformis. 
(iv) Muir-Torre syndrome. 
PRECUSSORS OF EPIDERMAL MALIGNANCIES 12 
1. Actinic keratoses (Solar keratoses) 13 
 Actinic keratoses are circumscribed, rough, epidermal lesions that develop 
on sun exposed skin secondary to chronic solar irradiation. Actinic keratoses 
(AK) are epidermal neoplasm, consisting of altered epidermal keratinocytes. 
They are classified as precancerous lesion because at least 20 percent will 
undergo transformation into invasive squamous cell carcinoma (SCC). 
Biologically, they are considered  to be carcinoma or squamous intraeidermal 
neoplasm (SIN). 
Clinical features: The Actinic keratoses are represented clinically by a rough 
lesion that is better recognized by palpation than inspection. Most lesions are 
between 3 & 6 mm in diameter. The AK may be flesh colored, darkly pigmented 
or erythematous. 
Treatment: Chemotherapeutic agents, surgical procedures, irradiation, cold steel 
or laser procedure. They can also be treated by sharp curettage followed by 
electrodessication. Cryosurgery with liquid nitrogen is effective therapy for most 
Actinic keratoses. Topical chemotherapy like 5-FU and topical retinone has been 
advocated for the reversal of the sun damage to the skin. 
Prognosis: The prognosis is good but the lesions may progress to carcinoma. 
Squamous cell carcinoma that arises from Actinic keratosis rarely metastasizes. 
ii) Radiation induced keratoses. 
 Ionizing radiation used for either diagnostic purposes can induce 
premalignant keratoses.  
1. Treatment of internal malignancies 
2. Treatment of cutaneous malignances 
3. Treatment of benign skin tumours. 
4. Treatment of benign non-tumourous cutaneous conditions. 
Prognosis: The lesion is more aggressive than solar keratoses. 
Treatment: To remove individual lesion with curettage and electrodessication or 
excision. 
 
 
iii)  Arsenical keratoses.  
 It occurs most often on the acral skin, in particular on the volar surfaces. 
They are punctuate palmar and or plantar lesions. Hundreds of lesions may be 
present. There is usually symmetrical involvement. Prognosis is determined by 
the rate of invasive squamous cell carcinoma & its potential for internal 
malignant disease. 
iv) Bowen’s disease: 
 Dr. John Bowen is credited with the first description. It can occur on both 
sun exposed and non-exposed areas. It is an intraepidermal neoplasia of the skin. 
Clinical features: 
 Bowen’s disease is most often a slightly scaly, discrete, erythematous 
plaque with a sharp but with irregular or undulating border. The surface 
characteristics vary and include hyperkeratosis, fissures, pigmentation, erosions 
and ulcerations. The lesion usually grows in a slow but progressive manner. 
Bowen’s disease has been linked to at least four potential etiologic agents, actinic 
damage, arsenic ingestion, radiation therapy and viral agents. 
Treatment: It includes surgical excision, curettage, and cryotherapy with liquid 
nitrogen, lacal irradiation. Topical chemotherapy with 5 – FU, laser surgery and 
microscopically controlled surgery. 
 
Tar Keratoses: 
Keratoses and cancer of the skin following chronic exposure to tar, pitch, coal, 
soot and mineral oil. The lesions are karyolyic or waxy and occur on skin. 
SQUAMOUS CELL CARCINOMA 
DEFINITION: 
 Primary cutaneous Squamous cell carcinoma a malignant neoplasm of the 
keratinizing cells of epidermis. 
Epidemiology 
 Non-melanoma skin cancer is the most common form of human cancer, 
with an estimated incidence of 1 million cases per year. Basal cell carcinoma 
(BCC) accounts for 80% of these cases. SCC accounts for 20% non-melanoma 
skin cancers. 
Risk factors and pathogenesis  
1. Radiation: 80% of UV light induced SCC of the skin develops on the 
arms, head and neck. Ultraviolet light is biologically significant in UV B (280 -
320 nm wavelength) range. This mechanism of UV light carcinogens is attributed 
to chromosomal changes, induction of DNA mutations, altered DNA methylation 
and activation of oncogenes. Radiation is known to be immuno suppressive and 
may impede the usual tumour surveillance mechanism. 
 SCC more often found in areas of sun-exposed skin. A higher incidence of 
SCC is seen in lower latitudes. The incidence of SCC in proportionately related 
to chronic cumulative sun exposure. 
2. Immunosupression: Renal transplant patients have an inroad risk of SCC 
of the skin. Some studies have noted cyclosporine increases incidence of skin 
cancers. 
3. Human papilloma virus (HPV): The infection with HPV has been 
implicated in the pathogenesis of SCC. The HPV subtype 16 and 18 found to 
have the closest association with transformation to SCC. 
4. Hereditary: Xeroderma pigmentosa is a rare autosomal redessive disease. 
These patients develop SCC, BCC and malignant melanoma. Treatment is 
absolute sun avoidance. 
5. Oncogenes: Over expression of the p53 protein has been in up to 40% of 
SCC of the skin. No P53 reactivity was observed is normal skin. 
6. Chromosome abnormalities: Frequent loss of heterozygosity of markers 
from 3p (23%), 9p (41%), and 17p (33%) in seen. This finding suggests that 
there are certain genes important in the development of SCC of the skin. 
7. Chemicals: Arsenic, polycyclic hydrocarbons, Doxorubicin, Alkylating 
agents, mechloroethamine has also been implicated. 
8. Lymphopoliferative disease: Patients with CLL and Non Hodgkins 
lymphoma may develop aggressive SCC. Patients with cutaneous T-cell 
lymphoma are at increased risk for SCC (Sezary Syndrome). 
9. Scar carcinoma (MARJOLIN’S ULCER): Marjolin, in 1828, first reported 
the occurrence of SCC in long standing burn wounds. This lesion is most 
apparent in those wounds that are clinically unhealed or unstable. Changes 
include increase in size of the ulcer, change in the appearance, particularly with 
appearance of rolled and everted edges with surrounding induration. Lymphnode 
metastases are higher in this group UV induced SCC reaching up to 20%. 
10. Sinus tracts: Squamous cell carcinoma can develop in chronic sinus tracts 
e.g.; osteomyelites. The frequent site of involvement is the tibia. The pressure of 
ulceration or a mass in the region of the sinus is an indication for biopsy. SCC of 
the skin metastasizes to regional lymph nodes at the rate of 30%. 
HISTOPATHOLOGY 
 SCC’s grow at a rate of 1.85 mm per month. It behaves more aggressively 
and has a highest incidence of metastases because of its stromal independence. 
At the periphery of some SCC’s dermosomes may be absent, which allows tumor 
cells to appear to float free in the stroma. This allows tumors cells to be 
implanted in to lymph nodes, blood vessels, or adjacent normal tissue during a 
surgical procedure. Microfilaments are important for cell mobility and are most 
numerous in tendon cells at the advancing edge of a cancer. 
Microscopy 
• Full – thickness epithelial dysplasia or anaplasia (in situ). 
• Dysplasia or anaplasia in lower most epidermal layer with single 
cell on nested transgression across basement membrane         
invasive. 
• Hyperkeratosis with formation of atypical parakeratoses. 
• Individual cell zonal necrosis. 
• Keratin pearl formation. 
 
MODES OF LOCAL SPREAD. 
 SCC follow the path of least resistance as they spread through tissue along 
peridchondrium, periosteum, or tarsal plate, embroyonal fusion planes, vestiges 
of embryo genesis, appear to offer little resistance to penetration and spread of 
this tumors. SCC does not readily invade muscle, when it does, the spread in 
often parallel to the muscle fibres. 
 Perineural spread is more common in SCC than in BCC. Tumors affecting 
the nerves may spread in a centripetal and centrifugal direction and may travel a 
considerable distance. 
PATTERY OF METASTASES 
 SCC usually first metastases to the regional lymph nodes and distal spread 
in the absence of node spread in rare. Regional metastases usually occur within 3 
years from the time of treatment of the primary tumors. Unusual & atypical 
metastases also occur. Intransit and satellite lesions may also be seen. The most 
frequent sites for metastases are the lung, skin, bones and parotid gland. The 
five-year survival rate of metastases in SCC in 34%. 
HISTOLOGIC AND CLINICAL VARIANTS OF SCC 
1. SCC in situ (Bowen’s disease, Querat’s erythroplasia) 
 Two different forms of SCC in site exists. The first is Bowen’s (BD), and 
the second is non-invasive SCC arising within an AK. 
Non- invasive SCC 
 In Grade I, the SCC has not penetrated below the level of sweat glands. In 
some areas basal layer may be intact., 
 In Grade II, the invading cell mass is poorly demarcated from the stroma. 
Many of the nuclei are atypical, and only a few incompletely keraitinised horn 
pearls are present. 
 In Grade III, keratinisation is absent in many areas and the horn pearls are 
not present. Malignant dyskeratoses is observed. 
 In Grade IV, keratinisation is almost non-existent; almost all of the nuclei 
are atypical. 
2. Adenoid, Acantholytic or pseudoglandular SCC. 
 This variant of SCC in almost exclusively found in the sun exposed areas 
of elderly patents, especially the face and ears. Microscopically tumour appears 
nodular or cup shaped. 
3. Spindle cell SCC. 
 A poorly differentiated variant, the tumour cells are elongated and spindle 
shaped. They are often pleomorphic & have atypical nuclei. Mitoses are 
common. 
4. Clear cell carcinoma of the skin. 
 It is a rare variant of SCC, has significant incidence of perineural 
involvement  & metastatic spread. Numerous clear cells are intermingled with 
areas of typical keratinizing SCC. 
5. Signet ring SCC 
 It is unusual variant. These tumours are Polydifferentiated  invade deeply 
and frequently and recurs multiple times. Signet ring cells are formed by 
monofilaments arrangement around the nucleus in concentric rings. 
6. Verrucous carcinoma. 
 Ackerman first coined the term verrucous carcinoma in1948. In 1954, 
Arid et al, were the first in the English  literature of report cutaneous lesions 
termed epithelioma cuniculatum because the tumour resembled a rabbit warren. 
Etiology: Trauma & chronic irritiation have been suggested as contributory to 
development of verrucous carcinoma, especially because of its prosperity to 
develop in burn scar and on the plantar surface. 
Clinical manifestations: 
 The lesion is a warty surfaced, exophytic tumor, often with many sinuses 
that may exudates greasy, malodorous material upon pressure. It can grow to be a 
boggy fungating mass. Cutaneous lesions most often occur on the plantar surface 
of the foot but have been seen on the face, back, leg and hand. Duration of the 
tumour is variable, from 2 months to 44 years. 
Differential diagnosis: Plantar wart, corn, condyloma acuminatum, pyogenic 
granuloma, amelanotic melanoma, and eccrine poroma. 
 The course of verrucous carcinoma is usually indolent, but it can grow 
aggrsively locally. Distant metastatic spread has not been described. The 
prognosis is excellent. 
Pathology: It is low – grade differentiated SCC that is usually both exophytic & 
endophytic. Superficial papillomatosis, hyperkeratosis are classical features. 
Treatment: Surgical excision is the treatment of choice. Recurrence rates 
following excision range from 5% to 6%. If the margins are positive immediate 
reexcision is advised. 
 
 
TREATMENT OF SQUAMOUS CELL CARCINOMA 
1. Conventional surgical excision 
 This is regarded by many as the treatment of choice for primary SCC. 
Excision with primary closure. Local rotational or advancement flaps or full 
thickness graft to repair the defect when carried out by a trained operator, usually 
produces a good cosmetic result and provides the pathologist with a specimen 
that allows confirmation of the completeness of excision and identification of 
histological factors associated with increased risk of local and systemic 
recurrence. Although under treatment because of lateral or deep tumour 
extension may be identified in conventionally processed surgical specimens, 
there is potential to miss cases of imcomplete excision as only a small proportion 
of the tumour edge is examined using conventional histopathological techniques. 
Usually a margin of 5 to 10 mm is given during excision. 
2. Micrographic Surgical technique 
 Frederick E Mohs, in 1936 introduced the technique of systematically 
excision and mapping the excised tumours until obtaining normal tissue. 
 This technique has been used most widely for the treatments of recurrent 
tumors. Previously irradiated tumors, and anatomic sites with a high rate of 
recurrence. 
Advantages: Tissue preservation, lower recurrence rate, and a tumor free site for 
recurrence. 
Disadvantages: They include requirement of special staining, time consumption, 
inconvenience for the patient and expense. 
3. Field destructive therapies. 
 Their therapies rely on a physical insult that is lethal to the lesion to be 
treated. Healing of the wounds is by secondary intention. 
a. Cryosurgery: Uses liquid nitrogen via an application probe as spray. It is 
reserved for premalignant lesions and for the lesions located on the eyslids, face, 
ears, neck & trunk. Caution should be taken when treating the nasolabial fold, 
inner canthus of the eyes, and preauricular areas. 
b. Electro desiccation & curettage: A dull curette is used to remove the  
tumor. Although not sure, the curette will remove friable tissue & usually will 
spare normal issue. Local anesthesia is used. Electro desiccation then performed 
to give a 1 to 2 mm zone of tissue destruction in and about the wound. It heals by 
secondary intention. 
c.  Radiotherapy: Usually treatment is 400 cGY delivered in 10 to 16 fraction 
for tumor less than 5cm & 4500 to 4500 cGY in 15 to 30 fraction for larger 
tampon. The field of irradiation includes the lesion & 3mm margin. The 
irradiated area develops acute radiation dermatitis that resolves in 4 to 6 weeks. 
The 5 years cure rate for SCC in reported to be 90%. 
Disadvantages: 
1. Inconvenience of daily treatments 
2. Radiation alters tumor host interaction. 
3. Recurrence is difficult to treat because of persistent damage to the 
site of treatment. 
4. Potential risk of radiation induced tumors. 
This modality is reserved for patients over 65 years, debilitated 
patients & those with high surgical risk. 
d. The CO2 laser: A cutting instrument is used for patients with bleeding 
disorders on anticoagulants, or those patients with contraindication to the use of 
electro cautery. 
e.  The Nd: Yag laser: Is used for the treatment of SCC, as the light is 
absorbed deep into the skin, producing more extensive thermal necrosis at a 
deeper level. 
f.  Photodynamic therapy: This uses photosensitivity compounds that here 
the ability to bind specifically to tumor cells. E.g. Hematoporphyrin derivatives. 
This produces free radicals that damage the tumor on exposure to light to 630 
nm. 
Disadvantages: Photosensitivity for a period of weeks, with mandatory avoidance 
of all sunlight. It is applicable to multiple, difficult, metastatic or end stage 
lesions. 
g. Topical – 5- florourocil (5-FU): It is applied topically in the form of 5% 
cream or a 2% of 5% solution twice a day. Redness, soreness & swelling occurs 
within 3 weeks on the face and with in 6 weeks on the legs. Healing can take 3-6 
weeks, and usually retains the form of hypo-pigmented lesion. This treatment 
modality may have its place in those patients with multiple superficial lesions or 
in those patients for whom cosmetic results may be very important. 
h. Retinoids: Proved useful in the treatment of SCC. Oral iso -1-retinoate 
and e-retinoate have been used. 
Disadvantage: Patient intolerance and non- compliance secondary to nausea & 
anorexia with a concomitant increase in liver function tests. 
i. Immunomodualtion: Interferon – alpha 2b, alpha 2c & gamma have been 
used both as intralesional injections and as systemic modalities. Intralesional 
depositions of interferon – alpha 2b enhances local T cell mediated immune 
response to act on the tumour cells. 
Follow up: SCC that recurs or metastasizes usually does so with in 3 years the 
risk of metachronous lesions however remains throughout patient’s life. 
 
 
 
 
 
BASAL CELL CARCINOMA 
INTRODUCTION: 
 Basal cell carcinoma (Basal cell epithelioma) is a malignant epithelial 
neoplasm of the skin, which is derived from the basal cells of epidermis and 
adnexal structures. Most commonly arising in areas of chronic sun exposure. It is 
a slow growing tumour that rarely metastasizes. However, it is capable of 
causing extensive local tissue destruction and slow death if left untreated or 
inadequately treated. 
INCIDENCE & EPIDEMIOLOGY: 
 Basal cell carcinoma (BCC) is the most common cancer, which occurs in 
humans. BCC occurs most commonly in men & manifests between 40-50 year of  
age. 
Histiogenesis: It arises from 
1) Basal cells of the epidermis 
2) Infundibulum and outer root sheath of the hair follicle. 
3) Primordial epithelial germ cells  
4) Cells of the pilosebacious unit. 
I. Ultraviolet Exposure 
 The most common factor involved in the pathogenesis of skin cancer is 
UV Light (UVL). Fair skinned individuals who burn easily & tan poorly are of 
greatest risk for developing pre cancerous & cancerous lesions of the skin. The 
UVL rays most important in cancer carcinogenesis are 290 to 320 nm.(UVB) 
 When combined UVB and UVA are much core carcinogenic than when 
either in administered alone. Cumulative exposure to sunlight over a prolonged 
period (20 to 30 years) is required for tumour development. Epidermal DNA 
damage is thought to be the primary mechanism by which carcinogenesis is 
mediated. 
II.  Scars & tranma: 
 They also play a role in the development of BCC. It arises in superficial 
scars & burns; most of these tumors arise on the head & neck & not the 
extremities. 
 Besides burns, other form of trauma such cuts have also been associated 
with  the acute onset of carcinoma. 
III. Radiation exposure: 
 X-ray irradiation may give rise to BCC’s. The minimal amount of 
exposure necessary for carcinoma formation is a dose of 1000 rads. 
IV.  Arsenic: 
 Arsenic plays a role in cutaneous & visceral carcinogenesis Sources 
include well water, insecticide, medication, mining , smelting & sheep dipping. 
Superficial muticentric & nodular BCC’s have been observed in patients exposed 
to arsenic. 
V. Nitrogen mustard.   
 It is used topically for the treatment of Mycosis fungoides. It is a 
carcinogen & enhances photo carcinogenesis. 
VI. Chicken pox scars are more commonly affected. 
VII. Immunosuppression: 
 An increased incidence of malignant neoplasms is reported in 
immunosuppressed individuals. Immunodeficiency enhances photo oncogenesis. 
 
GROWTH AND MODES & SPREAD: 
 The stroma appears to be important not only in the induction of BCC but 
also in its survival. This marked stromal dependence explains why the BCC so 
rarely metastasize. An adequate blood supply is necessary for the survival 
BCC’s. Regression may occur centrally or peripherally. During growth the 
stroma surrounding the tumour is thin & there is minmal inflammation. 
Metastases with BCC are rare. Spread commonly occurs via the lymphatic to 
regional nodes & via the blood stream to the long bones & lungs. Other sites, 
including the skin, may be affected. Implantation in the lungs may also occur by 
aspiration of fragments of the tumours in head & neck region. 
 BCC can demonstrate aggressive local growth, spread, and destruction. 
BCC always follows the path of least resistance. It is for this reason that invasion 
of bone, cartilage & muscle is not common and occur last in the disease. Once in 
a plane there can be extensive spread of tumour & destruction of normal tissue. 
CLINICAL VARIANTS OF BCC 
I. Nodular BCC (Nodulo ulcerative, Rodent ulcer). 
 This is the most common variant of BCC. Typically lesion is a small pink 
or red, well-defined nodule with a transplant appearance and overlying 
telangectasias, ulceration may also occur. Melanin pigment may be present in 
visible amount. Although slow growing, these tumors may reach a large size and 
extend deeply. Thus the term rodent ulcer. 
II. Superficial multicentric BCC. 
 It is commonly found on the trunk and extremities. Areas of spontaneous 
regression characterized by scarring & hypo pigmentation may be present. 
Multiple lesions may also be present. 
III.  Morpheic BCC 
 It resembles a plaque of morphea (localized scleroderma). Typically, the 
lesion in is indurated, ivory in colour, with overlying telangectasia. The 
morphemic BCC in noted for its sub clinical spread and high recurrence rate after 
treatment. 
 
 
IV. Cystic BCC 
 Cystic degeneration in a BCC in not often clinically obvious. They may 
have clear or blur gray cystic appearance and exude a clear fluid if punctured or 
cut. 
V. Basosquomous Variety (Basal cell carcinoma with squamous metaplasia 
or metatypical carcinoma) 
 This variant of BCC is much more aggressive & destructive in its 
behavior & more likely to metastasize & recur after treatment. The more 
squamous cells in typical BCC give greatest potential for metastases. The 
incidence of metastases with this variant is 9.7% 
VI. BCC with on aggressive (Infiltrative or micronodular) Growth pattern. 
 These lesions are flat or only slightly elevated plaques they are ill defined 
in contrast to the purely nodular BCC. 
VII.  Premalignant fibroepithelioma of pinkus 
 This is rare variant of BCC. Lesions situated on the lower back. The 
typical lesion is a smooth, slightly red, moderately firm nodule that may be 
pedunculated. 
 
 
 
 
HISTOLOGY 
 Nests and cords of atypical basaloid cells with peripheral palisade. 
 Individual cell necrosis and mitotic activity. 
 Variably mucinous stroma 
 Stromal epithelial separation artifact 
 Adnexal differentiation common. 
TREATMENT 
SURGERY 
 Surgical excision is the most commonly used method of tumour treatment 
by surgeon. The minimal margin for resection of a basal cell cancer is 2 to 5 mm. 
A reasonable surgical strategy in the plan for resection of the lesion at one sitting 
with delay in the final closure of the surgical defect. The surgical site is dressed 
with an occlusive, moist dressing and second surgical procedure is scheduled 5 to 
7 days later when complex reconstructive options can be planned. In the case of 
positive surgical margins, immediate re-excision on early reoperation of a 
suspected recurrence is advised. 
MOHS MICROGRAPHIC TECHIQUE 
 Moh’s technique is based on two fundamental principles. First, that all 
basal cell cancers spread by contiguous growth and second, that all tumour cells 
must be excised to achieve a cure. 
Procedure 
There are two techniques: 
1. Fixed tissue technique 
2. Fresh tissue technique. 
1. Fixed tissue technique 
 This technique involves the application of a fixation, zinc chloride paste to 
a 1.0 to 2.0 cm zone surrounding the clinically evident tumour. In excising the 
fixed tissue, another, wider margin (up to 2.0 cm) is excised around the areas. 
This procedure is not used robustly because the fresh tissue technique allows 
more rapid completion of  the procedure without the pain of zinc chloride 
fixation, and primary repair of the defect. 
2. Fresh tissue technique 
 The clinically apparent border of the tumours is outlined with gentian 
violet and used to generate the surgical map with reference to regional anatomy. 
The affected area is painted & draped. The area in anesthetized by regional or 
local anesthetized by regional or local anesthesia 
 The tumour is debulked by simple curettage. This process may help to 
reduce the number of excisional layers necessary to eradicate the tumours. The 
first micrographic specimen is obtained though excision of the base of the lesion 
in a saucer like manner with a border of 2 to 3 mm of skin from the edge of the 
defect made by the curette. After the skin is superficially scored in a circle to 
indicate the area to be excised, a second set of score marks is made at the 
superior and inferior edges to preserve orientation of the specimen. These 
superficial incisions are made before the specimen is removed. 
 The piece of tissue is excised with the blade beveled slightly inward. The 
angle of the blade become more severely beveled as it cuts deep to  the surface 
until the plane of the incision is horizontal to the skin surface. This thin wafer of 
excised tissue has a thickness of 2-3 mm & is excised without any holes made in 
the specimen. The specimen is placed with proper orientation on an anatomically 
marked  transfer card. 
 The specimen is subsequently prepares for frozen section. To ensure 
proper orientation of the specimen, a schematic drawing of the surgical defect is 
made with reference to the regional anatomic landmarks. Aligning incisions are 
marked on the diagram. The excised tissue is cut into pieces, each 2 sq cms in 
size, which fit into the freezing chuck of the cryostat. Each of these blocks of 
tissue is given number, which is known as section number. Indelible marking 
dyes are applied to the opposing cut surfaces of the specimen. 
 Frozen sections are cut sequentially from each section. The technician 
begins with the first section & continues with each consecutive section. Optimal 
cutting temperature medium is placed on the cryostat chuck & the specimen is 
inverted & placed horizontally on the chuck so that deep margin faces up. The 
specimen molded so that skin margin is elevated until it is in the same plane as 
the rest of the specimen. The whole specimen in flattened with the heat extractor. 
The tissue is sectioned at a thickness of 4 to 8 mm. the first sections processed 
represent the deepest & most lateral margins & are most important. The section 
are dried on a slide warmer and stained with methylene blueor hemotoxylin-
eosin. After the sections are stained, a cozen slip is applied & each slide is 
carefully examined microscopically. If the residual tumour is present, the patient 
returns to the procedure room for removal of areas with persistent tumour. In this 
second stage of the surgical procedure, the excisions is performed in a manner 
similar to the first stage. 
3. Curettage & electrodessication. 
 The tumour is debulked using curette down to the normal tissue, which is  
indicated by the sound on curettage in contrast the tumour is soft & friable. 
Electrodessication is used to destroy any residual tumour cells & produce 
hemostasis. Used in superficial BCC, nodular BCC, selected cases of Bowen’s 
disease, keratoacanthomas and hypertropic actinic keratoses. 
Disadvantages & Contraindications. 
• Aggressive histology like Morpheic BCC, recurrent BCC & SCC. 
• Larger tumour more than 1 cm especially on face, recurrent. 
• Longer duration  of disease as they have tendency to become more 
infiltrative and break down into smaller more invasive tumour with 
fibrosis. 
• Tumours in high –risk areas like skin cancers along the embryonal 
fusion planes, which have the potential for deep invasion and 
higher rate of recurrence. Those areas include mid face under the 
eyes, preauricular & post auricular areas and the Para nasal, 
nasolabial & inner canthal areas. 
4. Cryosurgery (Liquid Nitrogen) 
 the advantages of the technique are that it requires no local anesthesia; 
there is no bleeding & scarring in very acceptable. Disadvantages include the 
lack of a specimen of a specimen for pathological evaluation and healing period 
that may take weeks. Morpheform, infiltrative and  recurrent lesions have a lower 
rate of cure with cryosurgery methods. 
5. The carbon dioxide laser 
 It is used on a cutting & cauterizing tool for the surgical removal of skin 
cancer. Nd YAG laser may be useful for field destruction because its light is 
absorbed deeply in the skin. 
6. Topical Chemotherapy: 
 5 FU, function as a local autotoxin agent and promotes on enhanced 
immunologic response at the local level. 
7. Topical & oral retinoids 
 These treatments have been shown to produce tumor regression but not 
complete cure. 
8. Intralesional interferon 
 Lesions are injected with 1.5 million 1U of interferon depot – alpha 2b, 
there times per week for 3 weeks. Cosmetic results are excellent. 
9. Photodynamic therapy 
 Hematoporphyrin or delta-amino levulinic acid makes tumour cells 
photosensitive to light of 625-630 mm. A disadvantage is patient remains 
photosensitive for weeks, requiring avoidance of sunlight. 
10. Systemic Chemotherapy 
 Cisplatin appears to be more effective. Temporary regression & palliation 
are goals of treatment. 
11. Radiation therapy 
 effective treatment generally involves 200 rad fractions administered 5 
days per week for a total dose of 5000 rads. Reduction is then performed with an 
additional 1000 rads delivered to the region at greatest risk for recurrence. 
Indication for adjuvant radiation therapy 
• Extra capsular spread of tumour beyond lymph node capsule 
• Nerve invasion 
• Vascular invasion 
• Lymphatic invasion 
• Close margin (<1mm) 
Disadvantages: They include capability or histological assessment, poor margin 
control in ill – defined tumours & radiation dermatitis. 
T N M Staging of Cutaneous Cancer AJCC Primary tumor staging, criteria 
for confirmer of the skin. 
Criteria. Criteria. 
Tx Not assessable 
To No evidence of primary tumor 
Tis Carcinoma in situ 
T1 Tumor 2 cm in greatest dimension 
T2 Tumor>2 cm & <5 cm in greatest dimension 
T3 Tumor >5 cm is greatest dimension 
T4  Tumor invades deeper structure (Cartilage, bone, muscle) 
AJCC Staging criteria for regional nodes of the head & neck. 
Stage  Criteria 
Nx Not assessable  
No No evidence of lymphatic metastases 
N1 Mitosis in single ipsilateral lymph node <3cm in greatest 
direction 
N2a Metastasis in single ipsilateral lymph node >3cm but 
<6cm 
N2b Metastases is multiple ipsilateral lymph nodes <6cm 
N2c Metastases is bilateral or contralateral lymph nodes <6cm.
N3 Metastases to any lymph node > 6cm. 
 
 
Stage Groupings for carcinoma of the skin. 
Stage Tumour Node  Metastases 
O Tis  No  Mo 
I  T1 No  Mo 
II T3  No Mo 
III  T4 No  Mo 
 Any Y N1 Mo 
IV  Any T N1  M1 
 
RECOMMENDED TREATMENT FOR SUBTYPES OF BCC 
1. Nodules > 1cm (Not in high risk area): Cryosurgery (may need to 
combine with curettage, are only for lesion <2cm). Excision radiation, 
Mohs surgery (If>2cm). 
2. Superficial Multicentric: Shave excision with curettage, currttage and 
electrodessication, 5-FU (may need to use with curettage or occlusion), 
Cryosurgery, excision (poor choice if multiple lesion on large lesion, 
and especially if on trunk), Radiation (extremely superficial X ray 
required; not a usual and preferred method of treatment), Mohs surgery 
(if recurrent). 
3. Morpheiforn: Mohs surgery, Excision (only if mohs surgery is not 
available), Radiation. 
4. Aggressive growth pattern (Any location): Mohs surgery, Excision, 
Radiation. 
5. Field fire: Mohs surgery (allow wound to on its own if possible), 
Excision, & cryosurgery are poor alternatives especially if possibly 
dealing with recurrent BCC. 
6. Recurrent: Mohs surgery, Excision (only if mohs surgery not 
available) 
7. Incompletely cured: Re excision in conventional manner or by mohs 
surgery. 
8. Unresectable and advanced disease: Cisplatin + Doxorubicin + 
Radiation,  
9. Systemic Metastases: Cisplatin + Doxorubicin; may use with radiation 
necessary. 
 
 
 
MELANOMA SKIN CANCER 
DEFINITION: 
 Melanomas are a product of malignant transformation of melanocytes, 
which are neural crest cells that produce pigment melanin. It most commonly 
occurs in keratnised, sun-exposed skin, but may also occur in unusual locations 
such as the retina of the eye and in mucous membrane of the nose, mouth, anus 
& uvula. 
Epidemiology 
 The worldwide increase in melanoma has been evident for the past several 
decades. 
 Armstrong and English found that rates varied from as low as 0.2 per 
1,00,000 in parts  of Japan to 40 per 1,00,000 is Queensland, Australia. Asian 
populations such as those in Hong Kong, Singapore, China, India & Japan 
experienced the lowest rates. Melanoma incidence has been found to be higher in 
populations residing closer to the equator, an indication of a positive correlation 
with sun exposure. 
Risk factors: 
1. Family history: Between 5% & 10% of melanoma patients have a 
family history of the disease. 
2. Personal Characteristics: Persons with blue eyes, fair & red hair and 
pale complexion are at higher risk for melanoma. Hair color is easier 
to evaluate than skin color. 
3. Skin reaction to sunlight: People who get sunburned easily and tan 
poorly are at a increased risk for melanoma. A recent case control 
study suggests that childhood sun exposure is protective only among 
those able to tan. 
4. Freckling: Freckling whether in childhood or adulthood is a 
characteristic pigmentation pattern relation to poor sun tolerance and 
to an increased risk of melanoma. 
5. Benign melanocytic nevi: The number of nevi rather than their size is 
related to higher melanoma risk. 
6. Anthropometric indices: Height, weight and body surface area have 
revealed a significantly increased risk for melanoma with increasing 
height in both sexes. The tallest persons were at increased relative risk 
than the shorter men. 
7. Immunosuppressive states: Renal transplant recipients may have an 
increased risk of developing melanoma. 
SUN EXPOSURE: 
 Exposure to sunlight is found to be the most important risk factor for 
melanoma. Conclusions relating sunlight exposure to melanoma include 1) 
correlation of melanoma with latitude & measured ultraviolet (UVB) radiation, 
increases as the latitude decreases, and those living in coastal regions have higher 
incidence. 2) The apparent protection of racial pigmentation & 3) the changing 
incidence related to migration. 
 Recent studies have indicated a decrease of ozone layer by 3% to 7% 
since 1969. Each percentage decrease in the amount of ozone causes melanoma 
incidence to increase by 1%. 
Fluorescent lights: At short lengths <295 nm, the absorbed dose of UV light 
from the florescent light may be greater than that from the sun. Chemicals, alone 
or in combination with UV radiation, can induce melanoma. 
Ionizing radiation: People are exposed to large variety of environmental 
xenobiotics through industrial processes such as food, drugs, cosmetics, air & 
water, especially the chlorinated swimming pool water & open swimming water 
polluted by halogenated compounds. 
Occupation: Occupational groups such as chemicals, chemical workers and 
chemical engineers have been found to have increase risk of melanoma. There is 
strong correlation between melanoma & high socioeconomic status. 
Diet: High intake of fat especially polyunsaturated fat is associated with 
increased risk. Krik patric et al., examined intake of vitamin A, victory 
antioxidants, and other dietary components for the risk of  melanoma. 
 
PATHOLOGY 
BENIGN SIMULATORS OF MELANOMA. 
A) Dvsplastic Nevus: In 1820 Dr. William Norris described dysphasic 
Nevus syndrome. The dysphasic nevus is a histopathologically intermediate step 
between the junctional Nevus & insitu malignant melanoma. It is also considered 
a marker for heritable malignant melanoma. A dysplastic Nevus may arise de 
novo or within pre-existing dermal nevic components. Clinically dysplastic  nevi 
resemble small melanomas. They are macular with an irregular shape or at most, 
slightly raised with a finely pebbled surface. The most striking feature is 
heterogenecity. 
Size     : often > 7mm 
Number     : Many (>50-100) 
Symmetry     : Symmetric 
Erosion \ulceration   : None. 
Location     : usually trunk > limbs >head 
Symptoms     : None  
Surrounding skin    :  Normal. 
B)  Atypical Melanocytic hyperplasia 
 It consists of proliferation of atypical cells. Clinically, these lesions appear 
as irregularly shaped, irregularly pigmented tan / brown macules. 
 
C) Spitz nevus 
 The compound nevus of spitz was first described by Sophie spitz. It is a 
benign Melanocytic nevus. The characteristic lesion is dome shaped, caused by a 
proliferation of nevomelanocytes in a variably hyperplastic epidermis. The 
characteristic architecture of spitz nevus consists of large, superficial nests, 
which become smaller nests in the deeper portions. Clinically, the compound 
nevus of spitz usually presents as pink tan, rapidly growing papule no greater 
than 0.5 to 1.0 cm in size. One helpful sign is discoscopy. 
D)   Spindle cell Nevus of Reed 
A variant of spits nevus described  by Dr. Richard Reed. The pigmented 
spindle cell nevus occurs on the dorsal surface predominantly in young women. 
It is a uniformly pigmented dark papule with a flare of pigment. 
 RADIAL GROWTH PHASE MELANOMA. 
Definition: Radial Growth phase melanoma describes the predominantly 
intrapidermal proliferative phase of malignant melanoma. The cells comprising 
the intraepidermal proliferation are  similar in morphology to the dermal cells. 
Mitosis is common in the intraepidermal component. 
 The radial growth phase of cutaneous malignant melanoma of all forms 
consists of a gradually expanding macular to slightly maculopapualar lesions in 
skin that is associated with micro invasion by single cells or small nests of cells. 
These lesions are not associated with risk for metastases & are virtually 100% 
curable by surgery. 
TYPES OF RADIAL GROWTH PHASE MELANOMA: 
1. SUPERFICIAL SPREADING  
2. LENTIGO MALIGNA 
3. ACRAL – LENTIGINOUS / MUCOSAL 
MELANOMA SITU: 
 Melanoma in situ refers to a purely intraepidermal process of malignant 
melanocytic proliferation. The clinical lesions of melanoma in situ usually 
resemble the lesions of the radial growth phase of either superficial spreading 
melanoma or acral lentiginous melanoma, but without  areas that are pigmented 
and palpable. 
VERTICAL GROWTH PHASE: 
 Vertical growth phase describes the onset of a process in which cells 
originating in the epidermis have the capacity to form an expansile  nodule in the 
papillary dermis and / or infiltrate the reticular dermis and subcutaneous fat. The 
vertical growth phase can arise de nova. In which case the lesion is designed 
Nodular Melanoma. 
VERIANTS OF VERTICAL GROWTH PHASE MELNOMA: 
MINIMAL DEVIATION MELANOMA: It is a histological variant of malignant 
melanoma and is thought to have intermediate prognostic implications. It may 
contain an intraepidermal or radial growth phase compinent. 
 If a radial growth phase component can be diagnosed as superficial 
spreading melanoma, lentigo maligna melanoma, or acral lentiginous melanoma 
and contains an expansive nodule with minimal deviation features in the dermis, 
the lesions designed Malignant Melanoma. 
NEVOID MELANOMA: Histologically appears benign but behaves with 
aggressiveness. Two predominant architectural patterns are observed (1) a dome- 
shaped pattern (spitzoid) and (2) a verrucoid pattern. 
DESMOPLASTIC MALIGNANT MELANOMA (DMM): It is another variant 
of vertical growth phase malignant melanoma. First described by Conley et al in 
1971. DMM frequently presents clinically as a pink to tan dermal or 
subcutaneous nodule in the head and neck region of elderly persons. 
 The hallmark histologic feature is the thick fibrotic collagenous stroma in 
the dermis, within which malignant spindle cells are arrayed. 
HISTOLOGIC PROGNOSTIC PARAMETERS: 
1) DEPTH OF INVASION OF THE TUMOUR: 
Anatomic Levels of invasion (Clark): The anatomic levels of invasion describe 
five levels based on anatomic landmarks. Level I is intraepidermal proliferation 
of melanoma cells without any invasive component – melanoma in situ. Level II 
is single – cell infiltration of the papillary dermis or infiltration by small nests of 
cells of  the same size as the intraepidermal nests. Level III is a  widening of the 
papillary dermis by an expansile nodule of tumour cells that compress the 
reticular dermis. Level IV is a broad infiltration of single cells into the reticular 
dermis. Level V is infiltration of tumour cells into the subcutaneous fat. 
CLARK’S MICROSTAGING CRITERIA 
Level Anatomic Depth of invasion 
I In situ melanoma confined to epidermis 
II Invasion into papillary dermis 
III Invasion to but not into reticular dermis 
IV Invasion into reticular dermis 
V Invasion into sub dermal fat 
 
2. LINEAR DEPTH OF INVASION: The linear depth of invasion according 
to Dr. Alexander Breslow is the measurement in millimeters from the top of 
granular cell layer to the deepest tumour cell. In an ulcerated lesion the measured 
depth of invasion is taken from the depth of the ulcer base rather than from the 
granular cell layer adjacent to the ulcer. A mucosal melanoma is measured from 
the most superficial keratinocyte to the deepest tumour cell. Traditionally lesions 
less that 0.75 mm are considered to be at low risk for metastases and virtually 
curable by surgery. Lesions in the range of 0.75 to 1.5 (0.86 -1.69) mm are 
considered to be in the  intermediate to low risk range and  are associated with 
onset of the early vertical growth phase. Lesions in the range of 1.5 to 4.0 mm 
are intermediate to high risk, and lesions greater than 4.0 mm are definitely high 
risk. 
3. PHASE OF TUMOR PROGRESSION: Horizontal or radial growth phase 
lesions are curable by surgical excision, and lesions in the vertical growth phase 
have a risk for metastases that sequentially increases with the progressive 
measured depth of invasion. 
4. HISTOGENIC TYPE: Lentigo maligna melanoma was considered to have 
a better prognosis than other types of melanoma, nodular melanoma has a worse 
prognosis. 
5. HOST RESPONSE: The presence of an inflammatory infiltrate composed 
predominantly of lymphocytes is a favorable prognostic indicator, Clark et al. 
6. REGRESSION: In the vertical growth phase, regression is recognized as 
areas of dense fibrosis containing macrophages within a given tumour nodule. 
Regression was found by Clark et al , to have a favorable prognostic significance 
when defined as the absence of tumors in both the epidermis and fibrotic dermis. 
7. ULCERATION: Thicker tumours more commonly ulcerate. Ulceration, 
greater than 6 mm in depth was shown to have a striking difference in survival at 
5 years according to Day and co-workers. 
8. MITOTIC RATE: The mitotic rate of the vertical growth phase is a 
significant parameter. If the mitotic rate was greater than 6/ mm2 the survival rate 
was 40%, whereas those with less than 6/ mm2 had an 80% survival rate, Kopf 
and associates. 
9. MICROSCOPIC SATELLITES: Day et al found that isolated nests of 
tumour and measuring 0.05 mm in diameter or greater has a significant effect on 
survival. The presence of these nests, called microscopic satellites. 
 
 
 
 
 
 
 
  
 
 
 
 
 
TNM STAGING OF MALIGNANT MELANOMA 
Classification Thickness (mm) Ulceration status 
T1 <1.0 a. Without ulceration and level II /III 
b.  With ulceration or level IV /V 
T2 1.01 -2.0 a.  Without ulceration 
b.  With ulceration 
T3 2.01 – 4.0 a.  Without ulceration 
b.  With ulceration 
T4 >4.0 a.  Without ulceration 
b.  With ulceration 
 
Classification No.Of Metastatic Nodes Nodal Metastatic Mass 
N1 1 node  a. Micro metastasis 
b. Macrometestasis 
N2 2 or 3 nod5es a. Micro metastasis 
b. Macrometestasis 
c. In transit metastasis (es) / 
satellite (s) without metastatic 
nodes. 
N3 4 or more metastatic nodes, 
or matted nodes, or in transit 
metastasis (es) / satellite (s) 
with metastatic node(s) 
 
 
M. Classification Site  Serum LDH 
Level 
M1a Distant skin, subcutaneous or nodel 
metastasis 
Normal  
M1b Lung metastasis Normal 
M1c  All other visceral metastases Normal 
 Any distant metastasis  Elevated 
 
 
 
 
 
  
 
 
 
 
 
 
Clinical Staging Pathologic Staging 
0 Tis  NO  MO 0 Tis  NO  MO 
IA  TIa NO  MO  IA T1a  NO  MO 
IB T1b NO  MO  T2a  NO  MO 
 T2a NO  MO  T2a  NO MO 
IIA T2b NO  MO  IIA 2b NO  MO 
 T3A  NO MO   T3a NO MO 
IIIB T3b NO MO IIB T3b NO MO 
 T4a NO MO  T4a NO MO 
IIC T4b NO MO IIC T4b NO MO 
III Any T Any N MO IIIA T1-T4a N2a MO 
     T1-T4a N2a MO 
    IIIB T1-T4b N2a MO 
     T1-T4b N2a MO 
     T1-T4a N1b MO 
     T1-T4a N2b MO 
     T1-
T4a,b 
N2c MO 
    IIIC T1-T4b N1b MO 
     T1-T4b N2b MO 
     Any T  N3  MO 
IV  Any T Any N  Any M  IV Any T Any N  Any M 
 
 
 
 
RECOMMENDED SKIN MARGINS FOR WIDE LOCAL EXCISION 
FOR MELANOMA 
 
Primary site Thickness Recommended Margin 
Extremities  < 1mm  
1 – 4mm  
> 4 mm 
1 cm  
2 cm 
2-3 cm 
Head and neck All  1-2 cm 
Scalp All  2-3 cm 
 
ELECTIVE NODE DESSECTION 
 The rationale for ELND is based on the concept that melanoma 
metastasizes sequentially from lymph nodes to distant sites 
 Malignant melanoma can disseminate though both the lymphatic and 
hematogenous routes. For intermediate thickness lesions, the proportion of 
lymphogenous spread is higher than for thicker lesions. ELND be applied to 
patients younger than 60 and those with primary lesions 1 to 2 mm thick or 
combination of these two parameters, ELND has also been used for staging 
purposes. 
ELND should not be performed on  
1) Patients whose primary malignant melanoma are in situ or have a 
maximal thickness of less than 1mm. the incidence of regional  lymph 
node dissection is not justified. 
2) Patients whose primary malignant melanomas are in the midline of the 
head and neck or the trunk. Bilateral nodal dissections in these two 
regions of the body in the absence of a clearly demonstrable 
therapeutic advantage are not justified. Whether radioisotopic studies 
will greater the definition to this group remains to be seen. 
3) Elderly patients with serious intercurrent disease. They should not 
undergo ELND unless primary is very thick and lies directly over this 
nodal group. 
4) Patients with systemic metastases. 
 
SENTINEL NODE BIOPSY: 
 Morton et al, developed the method of intraoperative lymphatic mapping 
and sentinel node biopsy. The sentinel node identified and subjected to frozen 
section. When the node is negative the procedure is terminated. When the 
sentinel node is positive, about 37% probability exists that additional node(s) are 
positive and therefore a complete node dissection is required. 
 
 
THERAPEUTIC NODE DISSECTIONS: 
 1) Groin Dissection   2) Axillary node dissection 
 3) Neck dissection   4) Popliteal node dissection 
ADJUVANT TREATMENT FOR PATIENTS WITH POSITIVE 
REGIONAL NODES: 
 
 Adjuvant treatment with interferon -2b increases significantly, the 5 years 
disease free survival of patients from 26% to 37% 
 
INTRANSIT METASTASES: 
 Local recurrence is considered as that occurring with in 2cm of the 
surgical scar of the primary site. It should be treated with wide resection as a 
primary lesion, supplemented ideally  by regional perfusion or infusion. Intransit 
metastases are those occurring beyond 2 cm from the primary site and are usually 
muttiple, they may occur at any place between the primary site and the regional 
lymph nodes as skin or subcutaneous nodule. 
 The standard treatment is hyperthermic perfusion. Residual lesion is 
resected. Intralesional bacillie Calmette – Guerin some has been used in the past 
with some success among immunocompetent patients. Intransit lesions of the 
trunk are not amenable to regional chemotherapy. 
RESECITON OF DESTANT METASTASIS: 
 Malignant melanoma disseminates widely through the hematogenous 
route. It can involve any organ or tissue. Patients likely to benefit from resection 
of distant metastases are those with a relatively small number of lesions. Surgery 
for distant metastatic disease is also indicated for the palliation of symptoms. 
ISOLATED HYPERTHERMIA AND CHEMOTHERAPY PERFUSION: 
 The goal was to deliver the maximally tolerated chemotherapeutic does to 
a regionally confined tumour area while limiting systemic toxicity. Isolation was 
further enhanced by appropriately placed proximal tourniquets. 
DRUGS AND DOSAGES: 
 Melphalan (Alkeran), known as pheylalanine mustard, has been the drug 
of choice. Malphalan is usually given in 150 to 200 – mg aliquots into the arterial 
line at 3 –min intervals. Melphalan perfusion is continued for 1 hour. The M.D 
Anderson staging system is used because it fits the clinical situation for limb 
melanoma. 
  
 
 
 
M.D ANDERSON STAGING SYSTEM 
Stage  Definition 
I Primary diseases 
II Local recurrences or satellites within 3cm of the original tumour 
III A Intransit diseases more than 3cm from primary tumour 
IIIB  Regional node involvements 
IIIAB Intransit diseases and positive nodes 
IV  Distant diseases metastases (includes positive iliac of supraclavicular 
nodes) 
 
CHEMO IMMUNO AND RADIO THERAPIES IN THE TREATIMENT 
OF MELANOMA: 
 
I. CHEMOTHERAPY: 
 The best –studied single agents for the treatment of melanoma are 
dacarbazine (DTIC) nitrosoureas, interleukin – 2, and interferon – alpha 
COMBINATION CHEMOTHERAPY: 
 Three –drug combination have been developed that incorporate a vinca 
alkaloid such as vincristine into DTIC based combinations.  
 Two drug combinations of DTIC and cisplatin, DTIC and vindesine, 
vindesine plus eisplatin, have been evaluated. 
 Two combination regimens – BHD, which consists of carmustine (BCNU) 
hydroxyurea, and DTIC and BOLD, which includes bleomycin, vincristine. 
Lomustine (CCNU) and DTIC, induce response in 30% to 40% of treated paints. 
 Combination regiment reported to have a responses rate of 50% to 55% 
contains DTIC, CISPLATIN, BCNU AND tamoxifen (Darthmouth regimen). 
BIOLOGIC THERPY: 
 The combination of chemotherapy plus cytokines is called 
biochemotherapy or chemoimmunotherapy. Its underlying rationale is the 
combining of active agents with potentially different and complementary 
mechanism of action. 
II IMMUNOTHERAPY: In 1908, Paul Erlich proposed the possibility of 
using the immune system to eradicate tumour. Therapeutic manipulation of the 
immune system can be broadly designated immunotherapy. 
III  RADIATION THERAPY: 
 Sufficient biologic and clinical evidence now exists to refute that 
melanomas are uniformly radiation resistant. 
 Radiation therapy has been established as a simple and cost effective 
treatment modality for palliation of patients with symptomatic metstatic spread. 
PREVENTION OF SKIN CANCER: 
 There is broad consensus in the scientific community supporting the 
etiologic importance of sun exposure for both melanoma and nonmelanoma skin 
cancer. 
STAGE BASED INTERVENTIONS 
 There is an emerging consensus among behavioral scientists that matching 
intervention to the stages of change can enhance the efficacy and generalizability 
of treatment programs. These include: 
1) Sun Sensitivity Assessment and Feedback 
2) Sun scanner 
3) Sun damage instant photography 
BASIC FACTORS IN EARLY DIAGNOSIS: 
 To make a diagnosis, the physician must have a high index of suspicion 
and through knowledge of : 
1. The clinical characteristics of early malignant melanomas. 
2. The clinical features of the common types of pigmented lesion. 
3. The  characteristics of precussor lesions-e.g.Dysplastic nevi and 
certain congenital melanocytic nevi 
4. Other factors that increase the risk of developing a malignant 
melanoma –e.g. Familial history of malignant melanoma, many 
melanocytic nevi, excessive sun exposure, light coimplexion, 
history of sunburns and susceptible age. 
Detection includes ABCDs (Asymmetry, Border irregularity, Color variation, 
Diameter enlargement). 
DANGER SIGNS OF MALIGNANT MELANOMA: 
 Charge in Color, Change in Size, Change in Shape, Changes in Elevation. 
Change in Surface, Change in Surrounding Skin, Change in Sensation, Change in 
Consistency. 
 A complete annual examination of the skin by a physician is 
recommended for everyone, supplemented by monthly self – examinations by the 
patient. 
SELF-EXAMINATION OF THE SKIN: 
 Routine self-examination of the  skin is inexpensive, non invasive, and 
free of danger. The patient takes part of the responsibility for identifying early 
malignant melanomas of the skin at time when such lesions curable most early 
malignant melanomas are macular and grow in diameter for some time before 
they become elevated. Flat lesions are almost always curable, whereas lesions 
that develop plaques, papules or nodules have a greater risk for metastases. The 
goal is to recognize early malignant melanomas when they are flat and curable. 
Malignant melanomas “ write the message in the skin with its own ink and 
therefore all the easy to see. Some see do not comprehend” Dr. Neville Davis. 
 
 
MATERIALS AND METHODS 
 All the 40 patients admitted in surgical wards of GRH Madurai as cases of 
skin malignancies during the period of November 2005 to October 2007 are 
included in our study as time bound study. 
Inclusion criteria: 
1. All patients admitted to surgical wards as cases or primary 
cutaneous malignancies. 
2. patients willing for surgery. 
Exclusion criteria: 
1. Patients of secondary cutaneous  malignancies 
2. Patients of cutaneous sarcoma 
3. Patients treated on OPD basis. 
4. Patients not willing for  surgery. 
Methods: 
 All the 40 patients admitted in the surgical wards as cases of cutaneous 
malignancies during our study period were included in the study. Method of 
study consists of  
1. Detailed history and physical examination 
2. Relevant systematic examination 
3. Histopathological diagnosis 
4. Study of various modes of treatment. 
 
Histopathological diagnosis: 
 The diagnosis of the cases was confirmed by histopathology. Edge biopsy 
was performed in large ulceroproliferative growths and subjected to 
histopathology. The enlarged regional lymph nodes were either subjected to the 
FNAC of the lymph nodes or excisional biopsy. 
Routine Investigations: 
 Hb%, urine routine, blood urea and serum creatinine were the basic 
investigation performed in all cases. 
Radiological Investigations: 
Investigations like  Chest X-ray, ultrasound abdomen were performed when 
indicated. 
 
 
  
 
 
 
 
OBSERVATION AND RESULTS 
TABLE NO.1 Age and Sex distribution of primary skin malignancies 
Sex  Age  
Male  Female 
Total  Percentage 
 
30-39 5 1 36 15% 
40-49 6 2 48 20% 
50-59 8 4 12 30% 
60-69 3 1 4 10% 
70-80 8 2 10 25% 
Total  30 10 40 100% 
 
Above table shows age & sex distribution of skin cancer in our study. 
There is male preponderance with 80% of male being offense with compound to 
20% females M.F. ratio being 4:1. 
  
 
 
 
 
TABLE 2: OCCUPATION 
Sex  Age  
Male  Female 
Total  Percentage 
 
Agriculture 20 2 22 55% 
Coolie 10 - 10 25% 
House wife - 6 6 15% 
Railway Employee 2 - 2 5% 
Total  32 8 40 100% 
 
 This table shows agriculture field worker (55%) suffers more skin cancer 
than any other form of occupation. This is due to increased rate of sun exposure 
and thus ultraviolet radiation on working outside in the field for long hours. 
 Chart 2: Skin cancer distribution in different occupation 
 
 
  
 
 
 
 
TABLE -3: TYPE LESION 
Symptom Total  Percentage 
Ulcerative  8 20% 
Ulceroproliferative 22 55% 
Nodule  6 15% 
Swelling with ulcer 4 10% 
 
 The above table shows type of the lesion, which predominates in my 
study. Of the four type ulceroproliferative (55%) is most common. Rest of the 
type has got almost equal presentation. 
Chart 3: Type of Lesion 
 
 
 
 
  
 
 
 
 
TABLE 4: SITE 
SITE  SCC  BCC  MM 
Face & Neck 6 8 -- 
Back & Gluteal ragion 10 - -- 
Leg  2 2 -- 
Foot 8 - 4 
 
 This table shows sites of distribution of skin cancer. In general lesions of 
lower extremity 40% predominate followed by face (35%). The highest density 
of nin melanoma skin cancer & melanoma in both sexes was on the usually 
exposed parts of the head and neck & the lowest density on rarely exposed sites. 
 
 
 
 
  
 
 
 
TABLE NO.5: PREDISPOSING FACTORS 
Factors SCC  BCC 
Chronic ulcer 9 2 
Chronic Sinus, osteomyelitis 1 -- 
Albinism  - 1 
Chronic sun exposure 16 7 
 In our study chronic sun exposure (65%) was the most common 
predisposing  factor found. We had one patient with albinism with basal cell 
carcinoma over face. Here all the patients are agricultural field worker and 
coolies and are considered as chronic sun exposed patients.  
 
TABLE 6: Lymph node 
Lymph node  SCC BCC MM 
Insignificant  8 0  
Significant 6 0 2 
  In our study totally 40% cancer had lymphadenopathy in that 8 cases 
(20%)  were significant and 8 cases were having insignificant lymphadenopathy. 
 
SIGNIFICANT LYMPHADENOPATHY 
 SCC can metastasize to regional lymph nodes at the rate of 30%. But in 
our study  it was found to be 24.4% of SCC. Because of the less no of cancer 
studied & for only one year duration, lymphatic spread can’t be compared to the 
standard. 
TABLE 7: Incidence of primary malignant tumor of the skin from  NOV 
2004 to OCT 2007. 
Malignant tumor  Total  Percentage 
Squamours cell carcinoma 26 65% 
Basal cell carcinoma  10 25% 
Malignant melanoma 4 10% 
Total  40 100% 
 
 
 Of the malignant tumor 26 were SCC and 10 were BCC & 4 were 
malignant melanoma. In our study the results are not correlated with the 
European & American population statistics in which basal all carcinoma is the 
commonest. 
 
 
 
OBSERVATION OF SQUAMOUS CELL CARCINOMA 
TABLE 8: SQUAMOUS CELL CARCINOMA AGE INCIDENCE 
Age group  No.Cancer Percentage  
30-39 2 7.7% 
40-49 2 7.7% 
50-59 10 38.4% 
60-69 4 15.4% 
70-80 8 30.8% 
 
 
 Regarding the age wise incidence in our study, it is more concentrated in 
the age group between 50-80 years. The youngest patient suffering from SCC 
was 30 yrs old and the oldest was 80 yrs old. The highest incidence was in 50-60 
age groups. 
 
 
  
 
 
 
TABLE 9: SQUAMOUS CELL CERCINOMA SEX INCIDENCE 
 The number of male cases affected is 22 & 4. SCC is  5 times more 
prevalent in males compared to females. The increased ratio can be explained by 
increased out door activity. 
 
SCC No of cases Percentage  
Male  22 84.6% 
Female  4 15.4% 
 
 
 
 
 
 
 
 
  
 
 
 
TABLE 10: Anatomic site 
Site  SCC Percentage 
Face & Neck 6 23.1% 
Back - - 
Thorax & upper extremities  - - 
Gluteal region 10 38.4% 
Lower extremities 5 38.4% 
 
 
 In our study SCC is most commonly seen in lower limbs followed by face 
& gluteal region. 
 
 
 
 
 
  
 
 
 
OBSERVATION OF TREATMENT OF SQUAMOUS CELL 
CARCINOMA 
 
 Squamous cell carcinoma comprises lesions all over the body with 
maximam occurrence at the lower extremities followed by face. In our study all 
the cancers were treated either curatively or palliatively. 
 The operability of the cancer were identified mainly by site & size of the 
primary tumors, number of lesions, tumour border, & involvement ofunderlying 
structure like bone & muscle. The palpable lymphnodes were subjected to 
FNAC. And  those, which were negative for malignancy, were treated with 
antibiotics. 
 In our study majority of primary tumors were treated with wide local 
excision with split skin Grafting (WLE & SSG). There were two cases of 
varrucous carcinoma, which were treated by WLE & SSG. 
 Two cases were presented with lesion on the fore foot and they were 
treated with transmetataral amputation.  
 Two patients with lesion over the leg were treated with WLE with 
reconstruction with  calf flap. The flap was well taken. 
 One patient with lesion over right leg, which was very large, was treated 
with Above  Knee amputation. 
 Two patients with lesion over left side of the nose was treated with WLE 
and forehead flap. This cancer was positive for tumour margin. 
 The patient was given two cycles of cisplatin and 5fU followed by 
radiotherapy. Case was followed for 3 mths with no local recurrence. 
Two patient were presented with significant inguinal lymphadenopathy. One 
patient was treated with radiotherapy to inguinal nodes & another with 
chemotherapy using CIsplatin and 5 – FU 
 In our study, low incidence of the amputation shows acceptability of the 
other forms of treatment over debilitating surgery. 
 
 
 
 
 
 
 
 
  
 
 
 
 
OBSERVATION AND DISCUSSION OF BASAL CELL CARCINOMA 
TABLE  11: Basal Cell Carcinoma Age Incidence 
Age Group No.Of cancer  Percentage 
30-39 4 40% 
40-49 4 40% 
50-59 - - 
60-69 - - 
70-80 2 20% 
 
 Basal cell carcinoma presents a great diversity of appearance & is known 
as great imitator. It is the most common skin malignancy noted in western 
countries. The table shows the distribution of BCC age wise. 
 
 
 
  
 
 
 
 
TABLE  12: Anatomic Site 
Site  No. Of cancer Percentage 
Nose  2 20% 
Angle of eye  2 20% 
Forehead  2 20% 
Neck  2 20% 
Lower limb 2 20% 
 
 
 The above table shows the site of BCC. All the lesions are above the line 
joining the lobule o fear to ala of the nose. There findings are similar to those 
published by Gold berg H. 
 
 
 
  
 
 
 
 
 
TABLE  13: SEX INCIDENCE OF BASAL CELL CARCINOMA 
BCC  No. Of Cases  Percentage 
Male  6 60% 
Female  4 40% 
 
 
 In the study Reizner GT & Chakong T-et al. showed basal cell carcinoma 
is more prevalent in females than males contrary to squamous cell carcinoma 
distribution. 
 Our study does not go in favour of the above study. 
 
 
 
 
  
 
 
 
 
TABLE  14: Occupational Incidence of Basal Cell Carcinoma 
Occupation  No. of cases  Percentage 
Agricultural labour  4 40% 
Coolie  4 40% 
House wife  2 20% 
Total  10 100% 
 
 No particular occupation has predilection for BCC even though 
agricultural labour (60%) are most common in our study. 
Presenting  complaint  
 In our study 6 patients presented with ulcer & 4 patients with nodules. 
Lesions of BCC can present as papule, ulcer & pedunculated mass. In our study 
no cases had significant regional lynphadenopathy or metastasis. Metastatic BCC 
is very rare, incidence reported being 0.0028%. 
 
  
 
 
 
 
OBSERVATION OF TREATMETN OF BASAL CELL CARCINOMA 
 In our study we had ten cases of basal cell carcinoma, six males and four 
females. One patient who was an albino, presented with ulcerative type of BCC 
over the neck. He was treated with wide local excision and primary closure. Rest 
nine patients were treated with wide local excision and spilt skin grafting.  
 A minimum of 5mm margin was given in all patients Chemotherapy & 
radiation were not used in any of the patients. 
 
 
 
 
 
 
 
 
  
 
 
 
 
OBSERVATION OF MALIGNANT MELANOMA 
 The lowest incidence rate of 0.1 -0.2 per 1,00,000 person per year were 
found in India. Incidence of melanoma normally increases steeply until 50 years 
of age. After that the rate slow down & some studies show melanoma incidence 
is slightly higher in females. It has increases incidence in people who work 
outside. All the above statement about the melanoma could not be studied in our 
series as we got only four cases out of 20 cases. 
DISCUSSION OF THE CASE 
1. Kannan 48 yr male, presented with ulcerative growth over right great toe 
for 2 months. Patient gave history of thorn prick to the same site 1 years  back. 
 On examination there was a 10x12 irregular dark brown to black ulcer 
with everted edge. Surrounding skin was hyper pigmented and had 2 palpable 
inguinal nodes. Edge biopsy of the ulcer showed malignant melanoma & FNAC 
of lymph node came as metastatic deposits fo malignant melanoma. 
 He was treated with below knee amputation withright inguinal block 
dissection and post operatively given one cycle of Dacarbazine. Patient lost to 
follow up. 
2. Yamuna, 52 Old female, presented with ulcerative growth over left sole 
for 1 ½ yr. 
 On examination there was an ulcerative growth 3x2 cm with everted 
edges. The ulcer was blackish brown in color. She had 3 palpable inguinal nodes. 
Biopsy of ulcer preved melanoma & FNAC of the lymphnode came as metastatic 
deposits of melanoma. 
 She was treated with wide local excision and inguinal block dissection. 
Postoperatively he was given 3 cycles of dacarbazine chemotherapy. Patient was 
followed for 3 mths without recurrence. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
DISCUSSION 
 Cutaneous malignancies have always posed a challenge to surgeous, who 
over the decade have attempted to tackle problem. There has been recent increase 
in the in the incidence of cutanieous malignancies woeldwide, which is aptly 
termed as ‘an epidemic of skin makignancies.’ Various modalities of treatment 
have evolved over time with major advances in recent times. 
 In our present study 40 patients were admitted to the surgical wards which 
were evaluated and treatment with various modalities. 
 In our study the mean age of presentation was 53 years with the 
commonest age group being 50-60 years. A study by T. Milan et al showed that 
there was increase in incidence with the increasing age. The high incidence of 
cutaneous malignancies with the increasing age is due to cumulated risk of sun 
exposure. 
Table  15. Comparision  of the age of presentation 
Age (Years) Present study No of cases  Milan et al No of cases 
15-29 0 2 
30-44 12 10 
45-59 14 13 
60-74 12 25 
75+ 2 18 
 
 In our study there were 28 male patients of non melanoma skin cancer 
(77.78%) and female patients (22.22%). According to  study by Chuang T Y, 
PopencuNA et al. Non melanoma skin cancer occurs predominantly in males 
when compared to females in the ratio of 3:1. Our study goes in favour of that 
study. 
Table   16 comparision of sex incidence 
Sex Chuang TY, Popencu NA et al  Present study 
Male  75% 77.78% 
Female  25% 22.22% 
 
 In the present study the squamous cell carcinoma predominantly present 
in the lower llimbs 76.9%. in a study by Bernstein et al the squamous cell 
carcinoma most commonly presented over head and neck and dorsum of hands 
which are sun exposed areas. In the present study basal cell carcinoma 80 percent 
of cases were preset over the head and neck. This goes in accordance with the 
study by McCormack C et al, where the most lesions were situated above the line 
joining the tragus and ala of the nose. 
 In the present study most common mode of presentation was 
ulceroproliferative growth (55%). We could not find any other study in support 
of our finding. 
 In their study, Kennedy C and Bajdik C D reported that basal cell 
carcinoma was most common among the  non melanoma skin cancer. In the 
present study squamous cell carcinoma was the predominant (72.22%) which 
doesn’t correlate with the literature. Since the present study involved only a 
small number of cases and it is a time bound study. The results could not be 
compared with the other studies. 
 In their study, Johnson T  M et al reported that exposure to UV radiation 
as the most common and important predisposing factor in the causation of Non 
melanoma skin cancer. In our study we found that of all the patients of non 
melanoma skin cancer 22 patients were agricultural workers (55%) and 10 
patients were manual labours (25%). Since all these patients were involved in 
outdoor work, they were considered  to be the individuals at risk of skin cancer 
because of sun exposure. In our study we had 9 patients of squamous cell 
carcinoma with history of chronic ulcer and 1 patient of history of chronic sinus, 
which were considered to be one of the redisposing factors for the causation of 
squamous cell carcinoma. 
 In our study all the patients who were clinically suspected as cases of 
cutaneous malignancies were subjected to edge biopsy of the lesion. The clinical 
diagnosis was confirmed by the Histopathological diagnosis. The enlarged 
lympth nodes were subjected to FNAC for the confirmation of tumour 
metastases. In our study only 4 cases of squamous cell carcinoma were positive 
for the metastatses (15.4%). According to the literature squamous cell carcinoma 
metastasizes at the rate of 30%. 
 In our study conventional surgical excision of wide local excision was the 
main modality of the treatment for the primary tumour. Because of lack of 
facility other modalities like Moh’s technique, electrodessication and curettage 
were not used. Moh’s  technique was  the ideal method of treatment for all the 
lesions, especially those situated over the head and neck. Other field destructive 
methods like radiotherapy, cryosurgery which are effective in the treatment of 
small lesions specially those over the face, head and neck which  help in 
preservation of skin. However these techniques will not assure negative margins. 
A minimum margin of 5mm to 10mm was given for excision of squamous cell 
carcinoma and minimum of 5mm margin was given for the excision of the basal 
cells carcinoma. Bradland DG, Zitelli JA, in their study reported that a minimum 
of 6mm margin is sufficient in the excision of squamous cell carcinoma and 
2mm margin for excision of basal cell carcinoma. 
 In their study Rowe DE et al showed the comparable efficacy of 
conventional surgical excision to that of Moh’s technique and electrodessication. 
In their study they reported the recurrent rate of 1-3.1% for Moh’s technique, 
3.7% for electrodessication and 8.1-10% for conventional surgical excision in the 
management of non melanoma skin cancer. In our study we did not have any 
recurrences in our follow up period. 
 In all the cases the defect after the wide local excision was closed by 
primary closure or split skin graft. Two patients with lesion over the leg were 
treated by calf flap for reconstruction. Two patients with lesions over the forefoot 
were treated by trans metatarsal amputation Two patient with a very large lesion 
over the right leg was treated by above knee amputation. In our study low rate of 
amputation showed the efficacy of wide local excision with adequate margin in 
the management of non melanoma skin cancer. 
 In our study Four patients of squamous cell carcinoma had metastases to 
the inguinal lymph nodes. One patient was treated with chemotherapy with 
cisplatin and 5-FU and the other patient with radiotherapy. One patient with 
positive surgical margin was treated with chemotherapy with ifosfamide and 
methotrexate with radiotherapy. There was no local recurrence in that patient 
during the follow up period of 3 months. 
 IN our study wide local excision was the main modality of the treatment. 
By following the minimal surgical margins prescribed by the literature we did 
not have the single local recurrence during the period of followup. 
 
 
 
 
 
CONCLUSION  
 The ubiquitousness, the protean manifestation and clinical importance 
makes cutaneopus malignancy ideal subject for study. However because of very 
nature of the disease its variability in sites of presentation, patient seeks 
consultation in diverse departments. Hence the study compiled in one 
department, as is the case study, and any statistical conclusions drawn may not 
fully represent the magnitude of the problem. However the study does serve of 
gain a prespective of the problem & to gain insight into the subject. 
 Even though the cutaneous malignancy has not reached the epidemic 
proportions as in westen countries, the magnitude of problem is large in this part 
of Tamilnadu. It is highly relevant study for surgeon because of the variety of 
clinical presentations and treatment possibilities available. 
 Among the primary malignant tumor of skin the incidence of squamous 
cell carcinoma was highest at 65% followed by BBC at 25%. 
 Males (80%) were more affected than females (20%). A high incidence 
was found in those people who work outdoors. 
 Lesions on the lower extremity (40%) predominate closely followed by 
lesion on head & neck (35%). 
 The incidence of SCC carcinoma was highest in lower limb. This may be 
related to repeated trauma and infection of that part. The cases in our study are 
from low socioesconomic status in whom the usage of foot wear is practically 
non existent, which may lead to repeated trauma.  
 The BBC occurrence most common in the region above the line joining 
the ear lobe & ala of nose which is in relation to increased sun exposure. 
 The squamous cell carcinoma although ubiquitous in distribution, occurs 
more commonly in lower limb. Trauma leading to a non healing ulcer or healing 
after months to year with scar formation shows malignant characteristics. The 
malignancy appears long often the original injury. 
 The edge biopsy was used as the main stay in the diagnosis. The 
anatomical site, number of lesion, tumous border, and size of lesion, age of the 
patient were considered while planning wide local excision. A margin of 0.5 cm 
to 1 cm was given in all cases. No recurrences were reported in our study. 
 Four melanoma cases were presented in our study. All the cases had 
lesions over lower limb with metastases in inguinal lymphnodes. Edge biopsy 
confirmed the diagnosis in all. Wide local excision with a margin of 2 cm and 
below knee amputation was performed. In two cases inguinal block dissection 
was done followed by chemotherapy with Decarbazine. 
 The future of skin cancer treatment belongs to immunotherapy. Either 
specific active immunization with appropriate vaccines or adoptive immuno 
therapy must be based on the principle of immune reaction. 
 Skin cancer can be prevented by adequate education of the public about 
the harmful effects of over exposure to sunlight & usage of foot wear which 
prevents repeated trauma. Early detection of premalignant, suspicious lesions by 
skin self examination must also be carried out.  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
SUMMARY  
 This study was conducted in the surgincal wards of Govt. Rajaji Hospital, 
Madurai November 2005 to October 2007 to evaluate various clinical 
manifestations, histopathological diagnosis and various treatment modalities used 
to treat primary cutaneous malignancies. 
 40 patients in the age groups of 30 to 80 years were included in our study, 
detailed history was taken and based on clinical diagnosis of primary cutaneous 
malignancy, biopsy of the lesions were performed. FNAC or biopsy of regional 
lymph nodes was performed when they were enlarged. 
 After confirmation of the diagnosis, must of the patients were treated by 
wide local excision followed by primary closure or split skin grafting. When the 
regional lymph nodes enlarged which were positive for tumour, patients were 
treated with inguinal block dissection with chemoradiation or chemoradiation 
alone. 
 Mean age of presentation was 53%. Males (80%) were most commonly 
involved compared to females (20%) in the ratio 4:1. Agricultural field worker 
(55%) was the most common occupational group involved. Ulceroproliferative 
growth (55%) predominate followed by lesions over face (35%). IN the present 
study chronic sun exposure (65%) was the most common predisposing factor 
found. Squamous cell carcinoma (65%) was the most common histological type 
in our study. In our study most patients (75%) were managed by wide local 
excision as the sole mode or the part of treatment.      
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHART 1 AGE AND SEX DISTRIBUTION SKIN CANCER 
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TABLE 2 SKIN CANCER DISTRIBUTION IN DIFFERENT OCCUPATION 
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TABLE 3 TYPE OF LESION 
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TABLE 4 DIFFERENT SITES IN SKIN CANCER  
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TABLE 5   Incidence of primary malignant tumor of the skin 
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TABLE 6 SQUAMOUS CELL CARCINOMA AGE INCIDENCE 
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CHART 7   SQUAMOUS CELL CERCINOMA SEX INCIDENCE 
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CHART 8  ANATOMIC SITE 
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ANNEXURE 
PROFORMA 
Name:     Age:   Sex: 
IP No.:    DOA:   DOD: 
Chief Complaints:   a. Ulcerative Growth  
 Nodule / swelling  
Discolored patches  
H/o Presenting illness: 
Ulcerative Growth / Nodule / Swelling / Discolored patches 
Duration: 
Number:  
Mode of onset – Sudden / insidious / previous mole  
Site:  
Size:  
Shape:  
Colour: 
Progress- Increasing / Remains same  
Secondary changes:  
Associated with pain:    
Associated with fever: 
Discharge: 
Others:  
Past History:  H/o similar swelling / ulcer patch  
   H/o Skin cancer  
   H/o Radiotherapy  
   H/o chronic exposure to chemicals  
   H/o chronic exposure to sun 
Family History: H/o similar complaints in the family member     
Personal History: Occupation  
    Habits: Smoking / Alcohol / Tobacco  
   Sleep: Disturbed / Good  
   Appetite: Good / poor 
Socioeconomic status:  
General Physical Examination: 
Built:   Nourishment: Pulse  
BP:   Temp:   Skin Complexion: Fair / Mod / Black  
Icterus:  Clubbing:   Pedal edema:  
Lymphadenopathy: Yes / No 
If yes Group:   Number:  Size: 
 Consistency:   Tenderness:  Fixity: 
 
Systemic Examination  
Per Abdomen: 
Respiratory System: 
Cardiovascular System: 
Central Nervous system:   
Local examination  
Ulcerative Growth / Nodule / Swelling / Discolored Patch  
Inspection:  
 Number:  
 Site: 
 Size:  
 Shape: 
 Colour: 
 Surface:  
 Border:  
 Floor: 
 Margin: 
 Edge: 
 Surrounding skin: 
 Skin over the swelling: 
 Discharge: 
 Satellite nodules: 
Palpation: Size: 
   Shape: 
  Tenderness: Non tender / tender  
  Temperature : Reduced / Normal  
  Surface:  
  Extent:  
  Plane of the swelling: 
  Borders: 
  Edge: 
  Base:  
  Bleeding / friability: 
  Adjacent structure / skin: 
  Sensation: 
Regional lymphadenopathy: Yes / No  
If yes  
Group:  Number:  Size: 
Consistency:  Tenderness:    Fixity: 
Clinical diagnosis  
Investigation: 
Hb%   TC:   DC:   ESR: 
Blood group:  Alb:  Urine Micro:   Sugar: 
Blood Urea:    LFT:    S. Bilurbin: 
Serum creatinine:  T. Protein 
FBS:    S. Albumin    Globulin 
Chart X-ray:   SGOT: 
Ultrasound abdomen: 
CT Scan:  Chest / Abdomen / brain ETC.  
  Primary  
FNAC: 
Secondary LN: 
Biopsy: 
Post-investigational diagnosis: 
Pre operative preparation 
Operative procedure: 
Histopathological report 
Final Diagnosis: 
Follow up:  
 
 
 
 
KEY TO MASTER CHART 
SCC - Squamous Cell Carcinoma 
BCC - Basal Cell Carcinoma 
MM - Malignant Melanoma  
Agri  - Agriculture    AKA – Above Knee amputation  
BKA  - Below knee amputation  FF - Forehead flap  
CF - Calf flap    HW - Housewife  
Insig Ing Ln – Insignificant Inguinal lymph node  
Ing BD – Inguinal block dissection  PC – Primary closure   
R. Leg – Right Leg     R FF -  Right fore foot   
RE – Railway employee    Reg -  Regional  
RGT – Right great toe    R glu -  Right gluteal region  
Sig Ing N – Significant inguinal lymph node  
SSG – Split Skin graft    SW - Swelling  
UG - Ulcerative Growth    UL  - Ulcer  
UGP - Ulceroproliferative growth  WLE  - Wide local excision                        
 
 
 
 
ABSTRACT 
AIMS AND OBJECTIVES 
 To study the various modes of presentation of cutaneous malignancies, 
clinical correlation with Histopathological diagnosis and the management by 
following standard procedures in the literature. 
MATERIALS AND METHODS: 
 All the patients admitted in the surgical wards at GRH Madurai as cases 
of skin malignancies during the period of November 2005 to October 2007 are 
included in the study. Patients who were not willing for surgery, patients of 
cutaneous sarcoma, cases of secondary cutaneous malignancies and patient 
treated on O P D basis were excluded from the study. 
RESULTS AND CONCLUSION: 
 Total of 40 patients (30 males and 10 females) were admitted in surgical 
wards as cases of skin malignancies. 65% of them were squamous cell 
carcinoma, 25% were basal call carcinoma and 10% were malignant melanoma. 
Most common mode of presentation was ulceroproliferative  growth and the 
lesions were most commonly found on the lower limbs (40%) followed  by 
lesions on the head and neck (35%). Most common age group affected was 
between 50-60 yrs. A high incidence  was found in those working outdoors. 
Early detection of lesion treatment with wide local excision gave satisfactory 
results. 
KEY WORDS:  Squamous cell carcinoma, Basal cell carcinoma, Malignant 
Melanoma, Moh’s technique. 
 
 
List of abbreviations 
AKA-Above knee amputation 
AK-Actinic keratoses 
BCC-Basal cell carcinoma 
BKA-Below knee amputation 
MM-Malignant melanoma 
SCC-Squamous cell carcinoma 
SSG-Split skin grafting 
Sw-Swelling  
Ul-Ulcerative 
Ul prol-Ulceroproliferative 
WLE-Wide local excision 
 
 
 
  
